KYORIN Holdings, Inc. (4569.T)
JPY 1440.0
(-0.89%)
JPY 1440.0
(-0.89%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 45.39 Billion JPY | 0.78% |
| 2022 | 45.04 Billion JPY | 1.37% |
| 2021 | 44.43 Billion JPY | -3.07% |
| 2020 | 45.84 Billion JPY | -7.44% |
| 2019 | 49.52 Billion JPY | 2.25% |
| 2018 | 48.43 Billion JPY | -8.18% |
| 2017 | 52.75 Billion JPY | -2.51% |
| 2016 | 54.11 Billion JPY | 3.1% |
| 2015 | 52.48 Billion JPY | 1.35% |
| 2014 | 51.78 Billion JPY | 2.05% |
| 2013 | 50.74 Billion JPY | 3.67% |
| 2012 | 48.94 Billion JPY | -5.58% |
| 2011 | 51.84 Billion JPY | 3.54% |
| 2010 | 50.07 Billion JPY | 2.13% |
| 2009 | 49.02 Billion JPY | 8.59% |
| 2008 | 45.14 Billion JPY | 4.84% |
| 2007 | 43.06 Billion JPY | 13.14% |
| 2006 | 38.05 Billion JPY | -1.27% |
| 2005 | 38.54 Billion JPY | 2.12% |
| 2004 | 37.74 Billion JPY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 11.2 Billion JPY | -2.98% |
| 2023 Q1 | 11.52 Billion JPY | -9.22% |
| 2023 Q4 | 11.54 Billion JPY | 1.74% |
| 2023 FY | 45.39 Billion JPY | 0.78% |
| 2023 Q3 | 11.34 Billion JPY | 3.36% |
| 2023 Q2 | 10.97 Billion JPY | -4.7% |
| 2022 Q3 | 11.51 Billion JPY | 12.01% |
| 2022 Q4 | 12.69 Billion JPY | 10.17% |
| 2022 Q1 | 10.54 Billion JPY | -5.13% |
| 2022 Q2 | 10.28 Billion JPY | -2.51% |
| 2022 FY | 45.04 Billion JPY | 1.37% |
| 2021 Q2 | 10.66 Billion JPY | -9.35% |
| 2021 FY | 44.43 Billion JPY | -3.07% |
| 2021 Q3 | 10.87 Billion JPY | 1.93% |
| 2021 Q4 | 11.12 Billion JPY | 2.25% |
| 2021 Q1 | 11.76 Billion JPY | 5.49% |
| 2020 Q1 | 11.08 Billion JPY | -19.05% |
| 2020 Q4 | 11.15 Billion JPY | -1.82% |
| 2020 Q2 | 12.24 Billion JPY | 10.47% |
| 2020 Q3 | 11.36 Billion JPY | -7.16% |
| 2020 FY | 45.84 Billion JPY | -7.44% |
| 2019 Q4 | 13.68 Billion JPY | 13.34% |
| 2019 Q1 | 11.75 Billion JPY | -5.07% |
| 2019 Q2 | 12.01 Billion JPY | 2.24% |
| 2019 Q3 | 12.07 Billion JPY | 0.52% |
| 2019 FY | 49.52 Billion JPY | 2.25% |
| 2018 Q1 | 11.83 Billion JPY | -15.8% |
| 2018 Q4 | 12.37 Billion JPY | 0.58% |
| 2018 Q2 | 11.91 Billion JPY | 0.62% |
| 2018 Q3 | 12.3 Billion JPY | 3.33% |
| 2018 FY | 48.43 Billion JPY | -8.18% |
| 2017 Q1 | 11.96 Billion JPY | -6.97% |
| 2017 Q4 | 14.05 Billion JPY | 12.4% |
| 2017 Q3 | 12.5 Billion JPY | -12.05% |
| 2017 Q2 | 14.22 Billion JPY | 18.85% |
| 2017 FY | 52.75 Billion JPY | -2.51% |
| 2016 Q1 | 12.81 Billion JPY | -0.26% |
| 2016 FY | 54.11 Billion JPY | 3.1% |
| 2016 Q3 | 14.11 Billion JPY | -1.4% |
| 2016 Q4 | 12.86 Billion JPY | -8.89% |
| 2016 Q2 | 14.31 Billion JPY | 11.7% |
| 2015 FY | 52.48 Billion JPY | 1.35% |
| 2015 Q3 | 12.91 Billion JPY | -2.52% |
| 2015 Q2 | 13.24 Billion JPY | -1.77% |
| 2015 Q1 | 13.48 Billion JPY | -0.93% |
| 2015 Q4 | 12.85 Billion JPY | -0.46% |
| 2014 FY | 51.78 Billion JPY | 2.05% |
| 2014 Q2 | 13.22 Billion JPY | 10.6% |
| 2014 Q3 | 12.99 Billion JPY | -1.75% |
| 2014 Q4 | 13.6 Billion JPY | 4.74% |
| 2014 Q1 | 11.95 Billion JPY | -4.88% |
| 2013 Q3 | 12.63 Billion JPY | -5.2% |
| 2013 Q4 | 12.57 Billion JPY | -0.48% |
| 2013 Q2 | 13.32 Billion JPY | 9.08% |
| 2013 Q1 | 12.21 Billion JPY | -5.97% |
| 2013 FY | 50.74 Billion JPY | 3.67% |
| 2012 Q1 | 11.76 Billion JPY | -13.05% |
| 2012 FY | 48.94 Billion JPY | -5.58% |
| 2012 Q4 | 12.99 Billion JPY | 5.05% |
| 2012 Q3 | 12.36 Billion JPY | 4.55% |
| 2012 Q2 | 11.82 Billion JPY | 0.57% |
| 2011 FY | 51.84 Billion JPY | 3.54% |
| 2011 Q2 | 12.44 Billion JPY | 0.1% |
| 2011 Q3 | 13.43 Billion JPY | 8.0% |
| 2011 Q4 | 13.52 Billion JPY | 0.66% |
| 2011 Q1 | 12.43 Billion JPY | -6.33% |
| 2010 Q2 | 12.15 Billion JPY | -8.38% |
| 2010 Q1 | 13.26 Billion JPY | 2.73% |
| 2010 FY | 50.07 Billion JPY | 2.13% |
| 2010 Q4 | 13.27 Billion JPY | 16.61% |
| 2010 Q3 | 11.38 Billion JPY | -6.37% |
| 2009 FY | 49.02 Billion JPY | 8.59% |
| 2009 Q2 | 12.65 Billion JPY | 10.37% |
| 2009 Q3 | 12 Billion JPY | -5.08% |
| 2009 Q4 | 12.91 Billion JPY | 7.55% |
| 2009 Q1 | 11.46 Billion JPY | -3.35% |
| 2008 FY | 45.14 Billion JPY | 4.84% |
| 2008 Q3 | 11.99 Billion JPY | 13.89% |
| 2008 Q4 | 11.85 Billion JPY | -1.1% |
| 2008 Q2 | 10.52 Billion JPY | 0.0% |
| 2007 FY | 43.06 Billion JPY | 13.14% |
| 2006 FY | 38.05 Billion JPY | -1.27% |
| 2005 FY | 38.54 Billion JPY | 2.12% |
| 2004 FY | 37.74 Billion JPY | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 43.63 Billion JPY | -4.024% |
| Takeda Pharmaceutical Company Limited | 2618.18 Billion JPY | 98.266% |
| Sumitomo Pharma Co., Ltd. | 542.17 Billion JPY | 91.627% |
| Shionogi & Co., Ltd. | 197.62 Billion JPY | 77.03% |
| Wakamoto Pharmaceutical Co.,Ltd. | 3.73 Billion JPY | -1114.953% |
| Nippon Shinyaku Co., Ltd. | 65.63 Billion JPY | 30.833% |
| Kaken Pharmaceutical Co., Ltd. | 29.02 Billion JPY | -56.394% |
| Eisai Co., Ltd. | 533.01 Billion JPY | 91.483% |
| Morishita Jintan Co., Ltd. | 5.28 Billion JPY | -759.428% |
| Hisamitsu Pharmaceutical Co., Inc. | 65.8 Billion JPY | 31.015% |
| Mochida Pharmaceutical Co., Ltd. | 46.26 Billion JPY | 1.885% |
| Fuso Pharmaceutical Industries,Ltd. | 11.55 Billion JPY | -292.928% |
| Nippon Chemiphar Co., Ltd. | 8.23 Billion JPY | -451.446% |
| Tsumura & Co. | 48.8 Billion JPY | 6.977% |
| Kissei Pharmaceutical Co., Ltd. | 33.32 Billion JPY | -36.223% |
| Torii Pharmaceutical Co., Ltd. | 19.53 Billion JPY | -132.354% |
| Towa Pharmaceutical Co., Ltd. | 63.73 Billion JPY | 28.777% |
| Fuji Pharma Co., Ltd. | 12.65 Billion JPY | -258.655% |
| Zeria Pharmaceutical Co., Ltd. | 40.46 Billion JPY | -12.184% |
| Taiko Pharmaceutical Co.,Ltd. | 4.15 Billion JPY | -992.013% |
| Daito Pharmaceutical Co.,Ltd. | 5.94 Billion JPY | -663.583% |
| SymBio Pharmaceuticals Limited | 5.22 Billion JPY | -769.19% |
| MedRx Co., Ltd | 959 Million JPY | -4633.577% |
| Mizuho Medy Co.,Ltd. | 2.87 Billion JPY | -1479.655% |
| Solasia Pharma K.K. | 1.47 Billion JPY | -2975.542% |
| Modalis Therapeutics Corporation | 2.37 Billion JPY | -1814.864% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 24.16 Billion JPY | -87.854% |
| Sawai Group Holdings Co., Ltd. | 35.43 Billion JPY | -28.115% |
| Cyfuse Biomedical K.K. | 735.18 Million JPY | -6074.67% |
| Toho Holdings Co., Ltd. | 99.81 Billion JPY | 54.522% |
| Koa Shoji Holdings Co.,Ltd. | 2.25 Billion JPY | -1911.042% |